Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

Media Releases

PhRMA Statement on India Supreme Court Decision on Glivec
WASHINGTON, D.C. (April 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec. This decision marks yet another example of the deteriorating innovation environment in India.  Innovation is critical in meeting unmet needs of patients and is particularly relevant in the context of changing healthcare systems. In order to solve the real health challenges of India’s patients, it is critically important that India promote a policy environment that supports continued research and development of new medicines for the health of patients in India and worldwide. Protecting intellectual...
Read more

Latest Releases

PhRMA Applauds Passage of Russia PNTR
12/6/2012
Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “We applaud Congress for approving Permanent Normal Trade Relations (PNTR) for Russia. Improving trade relationships with Russia will protect and bolster U.S. biopharmaceutical jobs and exports.
More
Fostering Access to Innovative Medicines in Indonesia
12/6/2012
Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today in response to the September 3, 2012 Indonesian Presidential Decree (76/2012) that grants compulsory licenses on nine innovative biopharmaceutical products:
More
PhRMA Statement on PCAST Innovation Report
12/3/2012
Washington, D.C. (December 3, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on the President’s Council of Advisors on Science and Technology (PCAST) report:
More
Innovative Medicines Help Turn HIV Infection into Chronic Disease
11/28/2012
Two New Reports Show Remarkable Progress in Treatment Options for HIV/AIDS
Washington, D.C. (November 28, 2012) — America’s biopharmaceutical research companies are currently developing 73 innovative medicines and vaccines to help the nearly 1.2 million Americans living with HIV infection today, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) released today.
More
PhRMA Statement on Clinical Trials, Research Collaborations and Washington Post Article
11/26/2012
The Washington Post story ‘Can Drug Research Still Be Trusted?’ presents a one-sided view of the critically important scientific endeavors that explore and ultimately discover and produce life-saving innovative medicines.
More
PhRMA Launches Second Annual China Days
11/26/2012
PhRMA Chairman Lechleiter to Meet with Government and Health Leaders to Discuss Policies to Support an Ecosystem for Medical Innovation
Washington, DC/Beijing (November 26, 2012) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched its China PhRMA Days 2012 (November 26-30). As a part of this year’s activities, John C. Lechleiter, Ph. D., chairman of PhRMA, will be meeting with officials from the Chinese government and scientific community involved in innovation policy, including those involved in science education, clinical trial infrastructure, and regulation of medical products to discuss policies needed to support an ecosystem for medical innovation in China.
More

Subscribe to our Email Updates